Michael Wolfe
Director de Operaciones en Switch Therapeutics, Inc. .
Perfil
Michael Wolfe is currently the Senior Vice President-Finance & Operations at Switch Therapeutics, Inc. He previously worked as the Director-Finance & Business Operations at Kezar Life Sciences, Inc. and as the Head-Research & Development Finance at Onyx Pharmaceuticals, Inc. from 2010 to 2014.
He obtained his undergraduate degree from California Polytechnic State University (San Luis Obispo) in 2000.
Cargos activos de Michael Wolfe
| Empresas | Cargo | Inicio |
|---|---|---|
Switch Therapeutics, Inc.
 Switch Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Switch Therapeutics, Inc. is an American biotechnology company that aims to treat a range of diseases affecting the central nervous system and systemic indications with significant unmet need. Switch is based in , and was founded by Dee Datta, who has been the CEO since incorporation. The company is pioneering a new type of medicine that integrates nucleic acid nanotechnology and RNA interference (RNAi) science. The company's novel gene knockdown approach, the Conditionally Activated siRNA (CASI) platform, is based on technology developed by renowned researchers in the field of RNA and drug development from Caltech, Harvard Medical School, and City of Hope. | Director de Operaciones | 28/03/2023 |
Antiguos cargos conocidos de Michael Wolfe.
| Empresas | Cargo | Fin |
|---|---|---|
| KEZAR LIFE SCIENCES, INC. | Director de Operaciones | 01/01/2023 |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Corporate Officer/Principal | 01/01/2014 |
Formación de Michael Wolfe.
| California Polytechnic State University (San Luis Obispo) | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| KEZAR LIFE SCIENCES, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
Switch Therapeutics, Inc.
Switch Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Switch Therapeutics, Inc. is an American biotechnology company that aims to treat a range of diseases affecting the central nervous system and systemic indications with significant unmet need. Switch is based in , and was founded by Dee Datta, who has been the CEO since incorporation. The company is pioneering a new type of medicine that integrates nucleic acid nanotechnology and RNA interference (RNAi) science. The company's novel gene knockdown approach, the Conditionally Activated siRNA (CASI) platform, is based on technology developed by renowned researchers in the field of RNA and drug development from Caltech, Harvard Medical School, and City of Hope. | Health Technology |
- Bolsa de valores
- Insiders
- Michael Wolfe
